# Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol

> **NCT01578057** · PHASE1 · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 28 (actual)

## Conditions studied

- Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol

## Interventions

- **DRUG:** tasimelteon
- **DRUG:** Ethanol
- **OTHER:** Placebo tasimelteon
- **DRUG:** Placebo ethanol

## Key facts

- **NCT ID:** NCT01578057
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578057, "Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01578057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*